GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?

GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access? …C0NTINUE READING HERE >>>

After years of shortages, the Food and Drug Administration (FDA) has now listed Novo Nordisk’s blockbuster diabetes and obesity medications Wegovy and Ozempic as “available.”

Semaglutide remains on the agency’s drug shortage list, but all FDA-approved forms of the drug are no longer labeled “currently in shortage.” The agency may soon determine the shortage is resolved and remove the drug from the list entirely.

When an FDA-approved drug is in shortage, compounding…

>